Stockreport

Galecto Reports Operating and Financial Results for the Year Ended December 31, 2022

Galecto, Inc.  (GLTO) 
PDF BOSTON, March 09, 2023 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company and world leader in galectin biology focused on the dev [Read more]